NCT05461131 - Pertussis Challenge Study in Adults Vaccinated With BPZE1 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 20, 2022

Primary Completion Date

July 25, 2023

Study Completion Date

October 26, 2023

Conditions

Pertussis/Whooping CoughBordetella Pertussis, Whooping Cough

Interventions

BIOLOGICAL

BPZE1

Live attenuated vaccine

BIOLOGICAL

Placebo

DRUG

Azithromycin

Antibiotic

OTHER

Bordetella Pertussis Challenge Strain

Challenge Strain

Trial Locations (2)

Oxford Vaccine Group, Oxford

University Hospital Southampton, Southampton